alexa Efficacy Of Shakuyaku-kanzo-to In The Treatment Of Paclitaxel Induced Muscle Pain: VAS Assessment
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Kaichiro Yamamoto
Posters: Transl Med
DOI: 10.4172/2161-1025.S1.009
Abstract
The efficacy of the Kampo medication Shakuyaku-kanzo-to (TJ-68, Tsumura & Co., Tokyo, Japan) is recognized in the treatment of muscle pain. In the present study, we used a visual analogue scale (VAS) as an indicator to provide a more objective evaluation of the effects of Shakuyaku-kanzo-to in treating the muscle pain associated with paclitaxel use. Subjects were 11 patients undergoing at least 2 courses of chemotherapy with paclitaxel and carboplatin, who had developed muscle pain during the first course of treatment (control course). For the next course of chemotherapy (Shakuyaku-kanzo-to course), these patients received 7.5 g/day of Shakuyaku-kanzo-to for 7 days beginning 2 days before the start of chemotherapy. Informed consent was obtained before starting the control course. VAS scores were recorded during the control and Shakuyaku-kanzo-to courses. Mean values were calculated for VAS scores from day1 through day7 for each course of treatment, and these mean values were compared for the control and Shakuyaku-kanzo-to courses. The statistical analysis was performed with Wilcoxon signed- ranks test. A P-value of less than 0.05 was considered to be statistically significant. VAS scores, expressed as mean ? SE, were 6.95 ? 0.62 and 3.32 ? 1.10 for the control and the Shakuyaku-kanzo-to courses respectively. This difference was statistically significant (p=0.0069). No notable adverse drug reactions were associated with the administration of Shakuyaku-kanzo-to. Shakuyaku- kanzo-to could be significantly effective against the muscle pain associated with paclitaxel treatment. We observed no notable adverse reactions to Shakuyaku-kanzo-to. This preparation is also inexpensive and well-suited for clinical applications.
Biography
Kaichiro Yamamoto was one of the pioneers in chemotherapy for cervical cancer at Kinki University Faculty of Medicine. He and his team developed some new combination chemotherapies for cervical cancer. He later became Professor and Chairman of Department of Obstetrics and Gynecology, Sakai Hospital, Kinki University Faculty of Medicine. He has served on the editorial boards of some scientific journals. He is a member of the Japanese Academies such as Society of Obstetrics and Gynecology, Clinical Oncology, Cancer, Gynecologic Oncology, etc.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]line.com

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords